Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

J Eur Acad Dermatol Venereol. 2024 Feb 3. doi: 10.1111/jdv.19821. Online ahead of print.

¹ Dermatology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
² Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.
³ Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
⁴ Departamento de Estadística, Universidad de Salamanca y Unidad de Bioestadistica del IBSAL, Salamanca, Spain.
⁵ Dermatology, Fundación Instituto Valenciano de Oncología (IVO), Valencia, Spain.
⁶ Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
⁷ Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
⁸ Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, CIBERER, Barcelona, Spain.
⁹ Dermatology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
¹⁰ Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain.
¹¹ Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain.
¹² Medical Oncology, Hospital San Pedro de Alcántara, Caceres, Spain.
¹³ Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
¹⁴ Dermatology, Hospital Universitari Mútua Terrassa, Barcelona, Spain.
¹⁵ Medical Oncology, Hospital Universitario Clínico San Cecilio, Granada, Spain.
¹⁶ Medical Oncology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.

No abstract available

Publication types